FADS2 and urinary bladder carcinoma: Both in vivo and in vitro experiments, including CCK‐8 assays, lipid peroxidation assays, iron measurements and ferroptosis‐related gene analyses, demonstrated that silencing FADS2 can trigger ferroptosis in bladder cancer cells.